Searched for
DRUG FAVIPIRAVIR
Hantavirus: Britain secures experimental Japanese drug to strengthen responseBritain has received experimental favipiravir from Japan to treat a deadly hantavirus outbreak. The drug is not licensed in the UK and its ...- COVID-19: Favipiravir shows hope in Mumbai trialWhile the WHO last week recommended that antiviral remdesivir not be used for severely ill Covid-19 patients, Mumbai doctors published the ...
- After tablets, Hetero working on antiviral medicine Favipiravir injectionsIf successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...
- Favipiravir fastest molecule to cross Rs 100 crFavipiravir, a drug used in the treatment of Covid-19 patients with mild symptoms, became the largest-selling medicine in India in Septembe...
- Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2,640"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are re...
- FDC launches 2 variants of Favipiravir in India at Rs 55 per tabletNew Delhi, Aug 25 () Drug firm FDC Ltd on Tuesday said it has launched two variants of the COVID-19 drug Favipiravir under the brand names ...
- Pharma euphoria may reverse soon, and how!Ipca’s export formulations business grew by 89 per cent to 1,500 crore. Sales of HCQ for the quarter totalled Rs 200 crore. The share price...
- Trial results show significant faster time to clinical improvement with Favipiravir: GlenmarkResults from the Phase 3 trial showed numerical improvements for the primary efficacy endpoint with 28.6 per cent faster viral clearance in...
- Drug firms get DGCI nod for Covid drug favipiravir despite inconclusive studyOn Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...
- Favirpiravir yet to find favour with ICMRHowever, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...
- Glenmark launches COVID-19 drug after DCGI nod; MRP at Rs 103 per tabletThe company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer p...
- Favipiravir and Remdesivir get approval for treatment“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...
- Glenmark Pharma surges 35%, sees biggest intraday rise in history on Covid-19 drug launchThe firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.
- Raghava Life Sciences in talks with formulators for potential Covid drug FavipiravirFavipiravir, a generic version of Avigan that is used to treat influenza in Japan, is being studied as an experimental drug in treating the...
- Russia enters final stage of clinical trial of drug to treat Covid patientsRussian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group on Friday announced the start of the final stage o...
- Russia inches closer to create drug to treat Covid-19Six leading medical centers in Moscow, Smolensk and Nizhny Novgorod are currently participating in clinical trials, including I.M. Sechenov...
- Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatmentStrides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...
- A Mumbai company is working on a potential coronavirus medicineFavipiravir, an off-patent drug originally owned by Japanese drug maker Fuji, holds potential against RNA viruses, one of which is Covid-19...
- Japan drug showing 'favourable' results: ChinaChina's National Centre for Biotechnology development claimed that the drug Favipiravir, developed almost 25 years back, showed 'favourable...
Load More
